Gender differences in severity of sickle cell diseases in non-smokers

Mehmet Rami Helvaci1, Orhan Ayyildiz2, Mehmet Gundogdu3

  • 1Mehmet Rami Helvaci, MD, Assoc. Prof. of Internal Medicine, Medical Faculty of the Mustafa Kemal University, Antakya, Turkey.

Insights

This study found that males with sickle cell disease (SCD) experience more severe symptoms and complications than females, regardless of smoking status. These findings suggest a significant role of sex in SCD progression and outcomes.

Area of Science:

  • Hematology
  • Genetics and Heredity
  • Clinical Medicine

Background:

  • Sickle cell disease (SCD) is a genetic blood disorder with significant morbidity and mortality.
  • Gender-based differences in disease severity and progression are increasingly recognized across various chronic conditions.
  • Investigating these differences in SCD, particularly in non-smokers, is crucial for understanding disease pathophysiology and tailoring treatments.

Purpose of the Study:

  • To investigate potential gender differences in the severity of sickle cell disease (SCD) among non-smoking patients.
  • To explore how red blood cell (RBC) transfusion history correlates with gender and disease severity indicators.

Main Methods:

  • A cohort of 269 non-smoking sickle cell disease patients was categorized into three groups based on cumulative red blood cell (RBC) transfusion history (Group 1: <10 units, Group 2: 10+ units, Group 3: 50+ units).
  • Data collected included prevalence of RBC transfusions, painful crises, and various clinical complications such as clubbing, chronic obstructive pulmonary disease (COPD), leg ulcers, stroke, chronic renal disease (CRD), and pulmonary hypertension.
  • Statistical analyses were performed to compare gender-specific outcomes across the transfusion groups.

Main Results:

  • Females had a higher prevalence of no RBC transfusions (7.2% vs. 3.7%) and no painful crises (13.8% vs. 6.0%) compared to males (p<0.05 and p<0.001, respectively).
  • A progressive increase in the prevalence of painful crises, clubbing, COPD, leg ulcers, stroke, CRD, pulmonary hypertension, and a higher male ratio was observed from Group 1 to Group 3 (p<0.05 for most).
  • Mean age at mortality was similar between genders (29.1 years for females vs. 26.2 years for males, p>0.05).

Conclusions:

  • The study indicates that males with SCD experience more severe disease manifestations and complications compared to females, even in the absence of smoking.
  • The observed disparities in disease severity, transfusion requirements, and complication rates suggest a significant influence of biological sex on SCD pathogenesis.
  • These findings highlight the need to consider gender as a critical factor in managing sickle cell disease and potentially in future therapeutic strategies.
Abstract

Related Concept Videos

Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
32.7K
COPD: Pathogenesis and Clinical Features01:20

COPD: Pathogenesis and Clinical Features

Chronic obstructive pulmonary disease (COPD) is a group of lung conditions that progressively worsen over time, including chronic bronchitis and emphysema. This cluster of diseases collectively leads to a gradual and irreversible decline in lung function over time.
The primary cause for the onset of COPD is cigarette smoking and exposure to air pollution. These hazardous factors initiate a chain reaction within the lungs, resulting in chronic inflammation, damage to the airways, and a...
2.1K
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations01:19

Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

Chronic Obstructive Pulmonary Disease, or COPD, is a long-term condition marked by persistent and only partially reversible airflow limitation. It involves two overlapping conditions—chronic bronchitis and emphysema—which often co-appear but differ in dominant symptoms and underlying mechanisms.Chronic Bronchitis FeaturesChronic bronchitis presents with a persistent productive cough and thick, sometimes purulent mucus due to airway inflammation, enlarged mucus glands, and goblet...
30
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
48
Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
5.0K
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies01:27

Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies

Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
3.4K